Loretta Nastoupil

Academic History

Loretta J. Nastoupil, MD, is an oncologist with Southwest Oncology and CommonSpirit in Durango, CO. Dr Nastoupil is board certified in internal medicine, hematology, and medical oncology, and has extensive experience in research, teaching, and patient care.

Dr Nastoupil received her medical degree in 2007 from the University of Texas Southwestern Medical Center in Dallas, TX, after which she completed her clinical residency in medicine at the Washington University School of Medicine in St Louis, MO, followed by a residency in hematology and medical oncology at the Emory University School of Medicine in Atlanta, GA. Prior to moving to Southwest Oncology, she was an Associate Professor, Director of the Lymphoma Outcomes Database and Section Chief of New Drug Development in the Department of Lymphoma and Myeloma at the University of Texas MD Anderson Cancer Center, Houston, TX.

Speaking on novel treatments and immunotherapies in non-Hodgkin lymphoma

Dr Nastoupil has been involved in a number of trials investigating novel agents and immunotherapies for patients with non-Hodgkin lymphomas (NHL). In the past, her primary research focused on examining the disparities in lymphoma survival as a way to try and curate more effective clinical trials for high-risk patients. In particular, Dr Nastoupil has investigated methods of addressing disparities which affect the use of chemoimmunotherapy among patients with diffuse large B-cell lymphoma (DLBCL). This has included translational work, molecularly profiling tumors from patients with DLBCL to identify biomarkers which may explain racial differences in the presentation and survival outcomes in DLBCL.